多功能99mtc -5-阿扎胞苷金纳米颗粒:配方,体外细胞毒性,放射合成和体内药代动力学研究。

IF 2.8 4区 医学 Q2 PHARMACOLOGY & PHARMACY Current drug delivery Pub Date : 2023-01-01 DOI:10.2174/1567201819666220325092122
Samar S Ezz Eldin, Hassan M Rashed, Amira H Hassan, Heba F Salem, Tamer M Sakr
{"title":"多功能99mtc -5-阿扎胞苷金纳米颗粒:配方,体外细胞毒性,放射合成和体内药代动力学研究。","authors":"Samar S Ezz Eldin,&nbsp;Hassan M Rashed,&nbsp;Amira H Hassan,&nbsp;Heba F Salem,&nbsp;Tamer M Sakr","doi":"10.2174/1567201819666220325092122","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>5-azacitidine is a very potent chemotherapeutic agent that suffers from certain disadvantages.</p><p><strong>Objective: </strong>This study aims to prepare gold nanoparticles as a new nano-formula of 5-azacitidine that can improve its bioavailability and decrease its side effects.</p><p><strong>Methods: </strong>5-azacytidine-loaded GA-AuNPs were prepared and characterized by UV-Vis spectroscopy, infrared (IR), and electronic transmission microscope (TEM). This new platform was characterized in vitro by measuring its zeta potential, particle size, and drug loading efficacy, and the anti-proliferative effect on the MCF-7 cell line was evaluated. In vivo biodistribution studies of <sup>99m</sup>Tc-5-aza solution and <sup>99m</sup>Tc-5-aza-gold nano formula were conducted in tumor-bearing mice by different routes of administration (intravenous and intra-tumor).</p><p><strong>Results: </strong>5-Aza-GA-AuNPs formula was successfully prepared with an optimum particle size of ≈34.66 nm, the zeta potential of -14.4 mV, and high entrapment efficiency. <sup>99m</sup>Tc-5-Aza-GA-AuNPs were successfully radiosynthesized with a labeling yield of 95.4%. Biodistribution studies showed high selective accumulation in tumor and low uptake in non-target organs in the case of the 5-Aza-GA-AuNPs formula than the <sup>99m</sup>Tc-5-azacitidine solution.</p><p><strong>Conclusion: </strong><sup>99m</sup>Tc-5-Aza-GA-AuNPs improved the selectivity and uptake of 5-azacitidine in cancer. Moreover, <sup>99m</sup>Tc-5-Aza-GA-AuNPs could be used as hopeful theranostic radiopharmaceutical preparation for cancer.</p>","PeriodicalId":10842,"journal":{"name":"Current drug delivery","volume":"20 4","pages":"387-399"},"PeriodicalIF":2.8000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Multifunctional <sup>99m</sup>Tc-5-azacitidine Gold Nanoparticles: Formulation, <i>In Vitro</i> Cytotoxicity, Radiosynthesis, and <i>In Vivo</i> Pharmacokinetic Study.\",\"authors\":\"Samar S Ezz Eldin,&nbsp;Hassan M Rashed,&nbsp;Amira H Hassan,&nbsp;Heba F Salem,&nbsp;Tamer M Sakr\",\"doi\":\"10.2174/1567201819666220325092122\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>5-azacitidine is a very potent chemotherapeutic agent that suffers from certain disadvantages.</p><p><strong>Objective: </strong>This study aims to prepare gold nanoparticles as a new nano-formula of 5-azacitidine that can improve its bioavailability and decrease its side effects.</p><p><strong>Methods: </strong>5-azacytidine-loaded GA-AuNPs were prepared and characterized by UV-Vis spectroscopy, infrared (IR), and electronic transmission microscope (TEM). This new platform was characterized in vitro by measuring its zeta potential, particle size, and drug loading efficacy, and the anti-proliferative effect on the MCF-7 cell line was evaluated. In vivo biodistribution studies of <sup>99m</sup>Tc-5-aza solution and <sup>99m</sup>Tc-5-aza-gold nano formula were conducted in tumor-bearing mice by different routes of administration (intravenous and intra-tumor).</p><p><strong>Results: </strong>5-Aza-GA-AuNPs formula was successfully prepared with an optimum particle size of ≈34.66 nm, the zeta potential of -14.4 mV, and high entrapment efficiency. <sup>99m</sup>Tc-5-Aza-GA-AuNPs were successfully radiosynthesized with a labeling yield of 95.4%. Biodistribution studies showed high selective accumulation in tumor and low uptake in non-target organs in the case of the 5-Aza-GA-AuNPs formula than the <sup>99m</sup>Tc-5-azacitidine solution.</p><p><strong>Conclusion: </strong><sup>99m</sup>Tc-5-Aza-GA-AuNPs improved the selectivity and uptake of 5-azacitidine in cancer. Moreover, <sup>99m</sup>Tc-5-Aza-GA-AuNPs could be used as hopeful theranostic radiopharmaceutical preparation for cancer.</p>\",\"PeriodicalId\":10842,\"journal\":{\"name\":\"Current drug delivery\",\"volume\":\"20 4\",\"pages\":\"387-399\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current drug delivery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/1567201819666220325092122\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug delivery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1567201819666220325092122","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 2

摘要

背景:5-阿扎胞苷是一种非常有效的化疗药物,但也存在一定的缺点。目的:制备金纳米颗粒作为5-氮杂胞苷的新纳米配方,提高其生物利用度,降低其副作用。方法:制备负载5-氮杂胞苷的GA-AuNPs,并采用紫外可见光谱(UV-Vis)、红外光谱(IR)和透射电镜(TEM)进行表征。通过测定该平台的zeta电位、粒径、载药效能等指标对其进行了体外表征,并对其对MCF-7细胞系的抗增殖作用进行了评价。采用不同给药途径(静脉给药和肿瘤内给药)对99mTc-5-aza溶液和99mTc-5-aza金纳米配方在荷瘤小鼠体内的生物分布进行了研究。结果:成功制备了5-Aza-GA-AuNPs配方,最佳粒径为≈34.66 nm, zeta电位为-14.4 mV,包封效率高。99mTc-5-Aza-GA-AuNPs成功放射性合成,标记率为95.4%。生物分布研究表明,与99mtc -5-阿扎胞苷溶液相比,5-Aza-GA-AuNPs配方在肿瘤中的选择性积累高,在非靶器官中的吸收低。结论:99mTc-5-Aza-GA-AuNPs提高了5-阿扎胞苷在肿瘤中的选择性和摄取。此外,99mTc-5-Aza-GA-AuNPs有望成为治疗癌症的放射性药物制剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Multifunctional 99mTc-5-azacitidine Gold Nanoparticles: Formulation, In Vitro Cytotoxicity, Radiosynthesis, and In Vivo Pharmacokinetic Study.

Background: 5-azacitidine is a very potent chemotherapeutic agent that suffers from certain disadvantages.

Objective: This study aims to prepare gold nanoparticles as a new nano-formula of 5-azacitidine that can improve its bioavailability and decrease its side effects.

Methods: 5-azacytidine-loaded GA-AuNPs were prepared and characterized by UV-Vis spectroscopy, infrared (IR), and electronic transmission microscope (TEM). This new platform was characterized in vitro by measuring its zeta potential, particle size, and drug loading efficacy, and the anti-proliferative effect on the MCF-7 cell line was evaluated. In vivo biodistribution studies of 99mTc-5-aza solution and 99mTc-5-aza-gold nano formula were conducted in tumor-bearing mice by different routes of administration (intravenous and intra-tumor).

Results: 5-Aza-GA-AuNPs formula was successfully prepared with an optimum particle size of ≈34.66 nm, the zeta potential of -14.4 mV, and high entrapment efficiency. 99mTc-5-Aza-GA-AuNPs were successfully radiosynthesized with a labeling yield of 95.4%. Biodistribution studies showed high selective accumulation in tumor and low uptake in non-target organs in the case of the 5-Aza-GA-AuNPs formula than the 99mTc-5-azacitidine solution.

Conclusion: 99mTc-5-Aza-GA-AuNPs improved the selectivity and uptake of 5-azacitidine in cancer. Moreover, 99mTc-5-Aza-GA-AuNPs could be used as hopeful theranostic radiopharmaceutical preparation for cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current drug delivery
Current drug delivery PHARMACOLOGY & PHARMACY-
CiteScore
5.10
自引率
4.20%
发文量
170
期刊介绍: Current Drug Delivery aims to publish peer-reviewed articles, research articles, short and in-depth reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. Modern drug research aims to build delivery properties of a drug at the design phase, however in many cases this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves. The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance. The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.
期刊最新文献
Enhanced Therapeutic Potential of Liposome-Coated Bushen Jianpi Recipe for Hepatocellular Carcinoma Exploring the Insights on Exosomes and their Utility in Treating Ophthalmic Disease: Delving into the Clinical Approval and Present Trials Lignin Nanoparticles as pH-responsive Nanocarriers for Gastric-Irritant Oral Drug Aspirin Lipid Nanoparticles as a Platform for miRNA and siRNA Delivery in Hepatocellular Carcinoma Applications of Inorganic Nanomaterials against Tuberculosis: A Comprehensive Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1